Sarepta Therapeutics Inc. (NASDAQ: SRPT) Stock Upgraded at SunTrust Banks Inc.

Analysts at SunTrust Banks Inc. upgraded shares of Sarepta Therapeutics Inc. (NASDAQ: SRPT) from to Reduce today. With a rating of Reduce on the shares, Sarepta Therapeutics Inc. has a 52-week high of $56.80. The one-year price target of $44.46 is less than the opening price of $52.02, causing a number of other analysts to report on the stock recently. Usually, after analysts issue an upgrade report on a stock, they will subsequently issue recurring revisions, such as a price target change.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Shares of Sarepta Therapeutics Inc. (NASDAQ: SRPT) opened at $52.02 yesterday trading between $51.95 and $56.80, and last traded at $55.73, which is an increase of $6.79 over the previous closing price.

Sarepta Therapeutics Inc. (NASDAQ: SRPT) now has a market cap of 2.67B.

21,126,825 shares traded hands yesterday, 95 percent above the norm, out of a total float 40,605,000. Heavy volume aggregation by institutional investors may be on the horizon as the combination of large increases in trading volume and price growth can be indicative components.

As with all possible breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to demonstrate that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain teams of analysts researching thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

Traders can make the best trades when they follow the trading habits of professional investors.

Trades for Sarepta Therapeutics Inc. (NASDAQ: SRPT) have ranged from $8.00 – 56.80, and the stock now has a 50-day MA of $28.17 and 200-day MA of $21.37. Today’s last price is 0.02% under the 52 week high of $56.80.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors look for companies that have been successful at growing their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Add a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.